Houston-based biotech company Bellicum Pharmaceuticals Inc. appointed Edmund Harrigan to its board.
Harrigan most recently served as the senior vice president of worldwide safety and regulatory at Pfizer Inc.
He has 28 years of industry experience in clinical development, regulatory affairs and business development.
Bellicum CEO Rick Fair said Harrigan's addition will be "instrumental" as the company develops treatments for cancers and rare blood disorders.